🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being performed to comply with regulatory requirements that a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-17
Trial ID
NCT02293148
This is a randomized, double blind, placebo and active (moxifloxacin open l...
Status
Completed
Location
Celerion, Inc.
Start Date
2023-07-11
Trial ID
NCT05927649
Treatments Being Tested
The purpose of this study is to determine whether BMS-791325 has an effect ...
Status
Completed
Location
Ppd Development, Llc
Start Date
2014-04
Trial ID
NCT02084953
Treatments Being Tested
The purpose of this study is to examine the effect of buprenorphine on QT i...
Status
Completed
Location
PPD Development, LP, Clinics
Start Date
2004-07
Trial ID
NCT01148537
This is a randomized, placebo-controlled, double-blind, 3-way crossover pha...
Status
Completed
Location
Research Site
Start Date
2017-09-06
Trial ID
NCT03258515
Treatments Being Tested
Evaluate the effect of multiple doses (once daily for 3 days each of HYD 80...
Status
Completed
Location
PPD Phase I Clinic
Start Date
2012-11
Trial ID
NCT02243241
Treatments Being Tested
This is a study designed to ascertain the effect of PF-04447943 on QT inter...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2016-06-29
Trial ID
NCT02785770
Treatments Being Tested
This is a randomized, double-blind (with respect to Tebipenem pivoxil hydro...
Status
Completed
Location
Celerion
Start Date
2020-01-19
Trial ID
NCT04238195
The purpose of this study is to investigate the effect of PH-797804 followi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-04
Trial ID
NCT01862887
Treatments Being Tested
A double-blind study to characterize the effect of ampreloxetine on cardiac...
Status
Completed
Location
Theravance Biopharma Investigational Site
Start Date
2021-01-18
Trial ID
NCT04688632